
July 2001
Medical Device & Diagnostic Industry
Selected Contents
EDITOR'S
PAGE:
Where Have All The Dot-Coms Gone?
Perhaps the Internet is just too good an idea. When something that spectacular,
that promising, comes along, it's very difficult not to become irrational.
COVER STORY:
Industry and the Internet: A Second Look
MD&DI's special Internet section examines how medical device manufacturers are coping withand profiting fromthe changing landscape of the Web.
Revisiting
Healthcare Markets on the Internet: Dot-Com or Dot-Gone?
Cliff Henke
Despite the disappearance
of many of the Web-based medical exchanges in the past year, surviving medical
technology dot-coms continue to make progress, quietly fulfilling their promises.
FDA's
Regulation of Internet Promotion and Advertising
Jeffrey K. Shapiro and Jonathan S. Kahan
Medical device
manufacturers must closely monitor the content of their Web sites and related
links to avoid being reprimanded by FDA for product adulteration or misbranding.
Collaborative
Commerce for the Global Economy
Michael J. Carroll and Christopher Williams
To compete in the
new economy, medical device manufacturers must take advantage of the Internet's
instant communications and collaborative platforms throughout the supply chain.
Satisfying
QSR Requirements with Collaborative Production Management Systems
Steven A. Vogel
A technology based
on the Internet and intranets can automate the tasks required for regulatory
compliance.
Creating
Electronic Catalogs for Greater Customer Interaction and Product Exposure
Lynda Brooks
With the proper
planning, medical device companies can publish product catalogs in a variety
of media from one master database.
Incorporating
the New HIPAA Privacy Rules into Medical Device Trials
Nancy J. Stark and Erica Heath
Medical device manufacturers who sponsor clinical trials have reason for concern
when it comes to the need for a fast, smooth trial process.
R&D DIGEST
A review of cutting-edge technologies
and medical innovations
THIS MONTH: Making stronger plastics * Miniprobe could reduce biopsy use * Micro-organs
restore liver function * Noble gases aid lung-disease detection
WASHINGTON
WRAP-UP:
FDA
Reverses Stance on Firm's News Release
James G. Dickinson
A medical device company's stock was sent reeling after FDA reacted adversely—and
publicly—to its press release. How much attention does the agency
pay to Wall Street?
MEDICAL
PLASTICS & BIOMATERIALS:
Enhancing Device Development
through Early Supplier Involvement
Todd Owens
Contract suppliers who get in on the development process early will be the most valuable and reap the largest rewards.
Larger, machinable
ceramic plates available.
Compounds are flexible after curing.
Company divides plants into subgroups, and more!



